Blueprint Medicines shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Blueprint Medicines
Tip: Access up to 7 years of quarterly data
All positions including Blueprint Medicines held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Blueprint Medicines by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $495M | 5.7M | 87.22 |
| 2024-09-30 | $498M | 5.4M | 92.50 |
| 2024-06-30 | $633M | 5.9M | 107.78 |
| 2024-03-31 | $593M | 6.3M | 94.86 |
| 2023-12-31 | $501M | 5.4M | 92.24 |
| 2023-09-30 | $276M | 5.5M | 50.22 |
| 2023-06-30 | $355M | 5.6M | 63.20 |
| 2023-03-31 | $223M | 4.9M | 44.99 |
| 2022-12-31 | $188M | 4.3M | 43.81 |
| 2022-03-31 | $315M | 4.9M | 63.88 |
| 2021-12-31 | $487M | 4.6M | 107.11 |
| 2021-09-30 | $450M | 4.4M | 102.81 |
| 2021-06-30 | $375M | 4.3M | 87.96 |
| 2021-03-31 | $394M | 4.0M | 97.23 |
| 2020-12-31 | $414M | 3.7M | 112.15 |
| 2020-09-30 | $331M | 3.6M | 92.70 |
| 2020-06-30 | $280M | 3.6M | 78.00 |
| 2020-03-31 | $210M | 3.6M | 58.48 |
| 2019-12-31 | $269M | 3.4M | 80.11 |
| 2019-09-30 | $265M | 3.6M | 73.47 |
| 2019-06-30 | $347M | 3.7M | 94.33 |
| 2019-03-31 | $270M | 3.4M | 80.05 |
| 2018-12-31 | $163M | 3.0M | 53.91 |
| 2018-09-30 | $225M | 2.9M | 78.06 |
| 2018-06-30 | $198M | 3.1M | 63.48 |
| 2018-03-31 | $318M | 3.5M | 91.70 |
| 2017-12-31 | $250M | 3.3M | 75.41 |
| 2017-06-30 | $125M | 2.5M | 50.67 |
| 2017-03-31 | $81M | 2.0M | 39.99 |
| 2016-12-31 | $21M | 740k | 28.05 |
| 2016-09-30 | $11M | 353k | 29.70 |
| 2016-06-30 | $12M | 595k | 20.25 |
| 2016-03-31 | $9.2M | 512k | 18.05 |
| 2015-12-31 | $14M | 534k | 26.34 |
| 2015-09-30 | $11M | 498k | 21.34 |